Literature DB >> 17761169

Characterisation of endothelin converting enzyme-1 shedding from endothelial cells.

Sanjaya Kuruppu1, Shane Reeve, A Ian Smith.   

Abstract

The aim of this study was to determine if endothelin converting enzyme-1 (ECE-1) like other members of this metalloprotease family undergoes ectodomain shedding. The release/shedding of catalytically active ECE-1 was measured by monitoring the fluorescence resulting from the cleavage of a specific quenched fluorescent substrate. Catalytically active ECE-1 was detected in the media of human umbilical vein endothelial cells, and was confirmed by mass spectrometry based assays. Specificity of cleavage was confirmed by using both narrow and broad specificity inhibitors. In conclusion we demonstrate and characterize for the first time, ECE-1 shedding from the surface of endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17761169     DOI: 10.1016/j.febslet.2007.08.028

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

Review 1.  ET-1 as a Sex-Specific Mechanism Impacting Age-Related Changes in Vascular Function.

Authors:  Andrew V Kuczmarski; Laura M Welti; Kerrie L Moreau; Megan M Wenner
Journal:  Front Aging       Date:  2021-08-31

2.  Applicability of green fluorescence protein in the study of endothelin converting enzyme-1c trafficking.

Authors:  Sanjaya Kuruppu; Nathalie Tochon-Danguy; A Ian Smith
Journal:  Protein Sci       Date:  2013-02-01       Impact factor: 6.725

3.  Soluble and catalytically active endothelin converting enzyme-1 is present in cerebrospinal fluid of subarachnoid hemorrhage patients.

Authors:  Sanjaya Kuruppu; Sherry H-Y Chou; Steven K Feske; Sarah Suh; Iresha Hanchapola; Eng H Lo; Mingming Ning; A Ian Smith
Journal:  Mol Cell Proteomics       Date:  2013-07-01       Impact factor: 5.911

4.  Nitric oxide inhibits the production of soluble endothelin converting enzyme-1.

Authors:  Sanjaya Kuruppu; Niwanthi W Rajapakse; Rhys A Dunstan; A Ian Smith
Journal:  Mol Cell Biochem       Date:  2014-09-17       Impact factor: 3.396

Review 5.  SheddomeDB: the ectodomain shedding database for membrane-bound shed markers.

Authors:  Wei-Sheng Tien; Jun-Hong Chen; Kun-Pin Wu
Journal:  BMC Bioinformatics       Date:  2017-03-14       Impact factor: 3.169

Review 6.  Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation.

Authors:  Anthony J Turner; Natalia N Nalivaeva
Journal:  Peptides       Date:  2022-02-10       Impact factor: 3.750

7.  Isoforms of endothelin-converting enzyme-1 (ECE-1) have opposing effects on prostate cancer cell invasion.

Authors:  L A Lambert; A R Whyteside; A J Turner; B A Usmani
Journal:  Br J Cancer       Date:  2008-09-09       Impact factor: 7.640

8.  N-terminal domain of Bothrops asper Myotoxin II Enhances the Activity of Endothelin Converting Enzyme-1 and Neprilysin.

Authors:  A Ian Smith; Niwanthi W Rajapakse; Oded Kleifeld; Bruno Lomonte; Nkumbu L Sikanyika; Alexander J Spicer; Wayne C Hodgson; Paul J Conroy; David H Small; David M Kaye; Helena C Parkington; James C Whisstock; Sanjaya Kuruppu
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

Review 9.  Pharmacological hypothesis: Nitric oxide-induced inhibition of ADAM-17 activity as well as vesicle release can in turn prevent the production of soluble endothelin-converting enzyme.

Authors:  Sanjaya Kuruppu; Niwanthi W Rajapakse; Helena C Parkington; Ian Smith
Journal:  Pharmacol Res Perspect       Date:  2017-10

10.  Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor.

Authors:  Rebecca A Lew; Fiona J Warner; Iresha Hanchapola; Michael A Yarski; Jay Ramchand; Jay Manohar; Louise M Burrell; A Ian Smith
Journal:  Exp Physiol       Date:  2008-01-25       Impact factor: 2.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.